Inter-societal Survey on the topical nasal treatments in Italy
Keywords:
Topical nasal therapy is a common way for administering remedies.Abstract
Topical nasal therapy represents a widespread opportunity to treat upper airway diseases. As a result, specialists in different areas (mainly ENT, pediatrics, and allergology) and general practitioners prescribe intranasal compounds. However, a myriad of products and devices are available, as well as respiratory disorders. Consequently, this matter is debatable, and no guideline organically addresses this issue.
Considering these premises, a restricted panel of qualified experts promoted an initial multidisciplinary survey involving only Fellows of some Scientific Societies belonging to ENT, pediatrics, and allergology areas. The survey included a series of queries concerning practical aspects of topical nasal therapy (treated disease, devices, and agents). A web platform served to participate in this survey. Each participant anonymously completed the questionnaire.
Four hundred and forty-five doctors participated in the survey. There was a homogeneous distribution in Italy. Most participants were pediatricians (37%), followed by allergologists (31%) and ENT specialists (24%). Almost all doctors (95%) used topical nasal therapy. The most common diseases topically treated were allergic rhinitis (79%), chronic rhinosinusitis (73%), and non-allergic rhinitis. The most popular devices were pre-dosed spray both for nasal irrigation (67%) and nebulization (66%). Corticosteroids (67%), isotonic saline (63%), hyaluronic acid, hypertonic saline, and antihistamines (39%) were the most common agents used for intranasal therapy. Combined antihistamine/corticosteroids were also commonly used (38%). The most frequent schedule was the cyclic treatment. Most doctors (89%) claim they adequately spend time educating patients on this matter.
In conclusion, topical nasal therapy is commonly used to manage upper respiratory diseases. However, the disagreement about some issues requires greater knowledge of the topics and the need to develop new studies, including pragmatic ones.
References
1. Varricchio A, Presutti L, La Mantia I, Ciprandi G. Inter-societal Delphi Consensus on the topical nasal treatments in Italy. Multidiscip Respir Med 2024;19(1):991.
2. Varricchio A, Brunese FP, La Mantia I, Ascione E, Ciprandi G. Choosing nasal devices: a dilemma in clinical practice. Acta Biomed 2023;94(1):e2023034.
3. Wise SK, Damask C, Greenhawt M, Oppenheimer J, Roland LT, Shaker MS, et al. A Synopsis of Guidance for Allergic Rhinitis Diagnosis and Management From ICAR 2023. J Allergy Clin Immunol Pract 2023;11(3):773-96.
4. Hellings PW, Lau S, Scadding GK, Bjermer L, Backer V, Chaker AM, et al. EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care. Front Allergy 2023;4:1236977.
5. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 2020;Suppl. 29:1-464.
6. Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol 2017;140(4):950-58.
7. Bousquet J, Schünemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol 2020;145(1):70-80.e3.
8. Dykewicz MS, Wallace DV, Amrol DJ, Baroody FM, Bernstein JA, CraigTJ, et al. Rhinitis 2020: A practice parameter update. J Allergy Clin Immunol 2020;146(4):721-67
9. Djupesland PG. Nasal drug delivery devices: characteristics and performance in a clinical perspective. Drug Deliv Trans Res 2013;3(1):42-62.
10. Jung M, Lee JY, Ryu G, Lee KE, Hong SD, Choi J, et al. Beneficial effect of nasal saline irrigation in children with allergic rhinitis and asthma: A randomized clinical trial. Asian Pac J Allergy Immunol 2020;38(4):251-7.
11. Nguyen SA, Psaltis AJ, Schlosser RJ. Isotonic saline nasal irrigation is an effective adjunctive therapy to intranasal corticosteroid spray in allergic rhinitis. Am J Rhinol Allergy 2014;28(4):308-11.
12. Head K, Snidvongs K, Glew S, Scadding G, Schilder AG, Philpott C, et al. Saline irrigation for allergic rhinitis. Cochrane Database Syst Rev 2018;6(6):CD012597.
13. Gelardi M, Taliente S, Piccininni K, Silvestre G, Quaranta N, Ciprandi G. Nasal irrigation with Nasir® in children: a preliminary experience on nasal cytology. J Biol Reg 2016;30:1125-30.
14. Frank DO, Kimbell JS, Pawar S, Rhee JS. Effects of anatomy and particle size on nasal sprays and nebulizers.
Otolaryngol Head Neck Surg 2012;146(2):313-9.
15. Kimbell JS, Segal RA, Asgharian B, Wong BA, Schroeter JD, Southall JD, et al. Characterization of deposition from nasal spray devices using a computational fluid dynamics model of the human nasal passages. J Aerosol Med 2007;20(1):59-74.
16. Keeler JA, Patki A, Woodard CR, Do F-I. A Computational Study of Nasal Spray Deposition Pattern in Four Ethnic Groups. J Aerosol Med Pulm Drug Deliv 2016;29(2):153-66.
17. Ciprandi G, Tosca MA. Non-pharmacological remedies for post-viral acute cough. Monaldi Arch Chest Dis 2021;92(1)
18. Ciprandi G, Tosca MA. Non-pharmacological remedies for the common cold. Minerva Pediatr (Torino) 2023;75(1):75-86.
19. Ciprandi G, Leonardi S, Zicari AM, Tosca MA, Marseglia G. Allergic rhinoconjunctivitis: pathophysiological mechanism and new therapeutic approach. Acta Biomed 2020;91(1):93-6.
20. Naso M, Trincianti C, Drago L, Daglia M, Brindisi G, Brunese FP, et al. Resveratrol: immunological activity and possible application in children and adolescents with
allergic rhinitis. Expert Rev Clin Immunol 2024:1-3. doi: 10.1080/1744666X.2024.2399705. Epub ahead of print.
21. Gori A, Brindisi G, Daglia M, Giudice MMD, Dinardo G, Di Minno A, et al. Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential Breakthrough. Nutrients 2024;16(12):1906
Downloads
Published
Issue
Section
License
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Mattioli 1885 has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
How to Cite
